High resolution CT and bronchial reversibility test for diagnosing COPD

Respirology

Volumn 10, Issue 3, 2005, Pages 316-322

  Kurashima, Kazuyoshi ^a   Takayanagi, Noboru ^a   Sato, Nagato ^a   Kanauchi, Tetsu ^a   Hoshi, Toshiko ^a   Tokunaga, Daido ^a   Ubukata, Mikio ^a   Yanagisawa, Tsutomu ^a   Sugita, Yutaka ^a   Kanazawa, Minoru ^b  

^a Cardiovascular and Respiratory Center ^*  (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bronchial reversibility test; COPD; High resolution CT

Indexed keywords

BRONCHODILATING AGENT;

AGED; AIRWAY CONSTRICTION; ARTICLE; ASTHMA; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PNEUMOCONIOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; SPIROMETRY; TUBERCULOSIS;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 22644436884     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00701.x     Document Type: Article

References (26)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung 3. Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-76.
2. Fabbri LM, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis management, and prevention of COPD update. Eur. Respir. J. 2003; 22: 1-2.
3. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: S77-S121.
4. Copley SJ, Wells AU, Muller NL et al. Thin-section CT in obstructive pulmonary disease: discriminatory value. Radiology 2002; 223: 812-19.
5. King MA, Stone JA, Diaz PT, Mueller CF, Becker WJ, Gadek JE. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996; 199: 137-41.
6. Hansell DM, Rubens MB, Padley SP, Wells AU. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology 1997; 203: 721-6.
7. Nishimura K, Kitaichi M, Izumi T, Itoh H. Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings. Radiology 1992; 184: 779-85.
8. Niimi A, Matsumoto H, Amitani R et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am. J. Respir. Crit. Care Med. 2000; 162: 1518-23.
9. Nakano Y, Muro S, Sakai H, Hirai T, Chin K. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J. Respir. Crit. Care Med. 2000; 162: 1102-8.
10. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the varidity of different diagnostic tests in adults with asthma. Chest 2002; 121: 1051-7.
11. Anthonisen NR, Wright EC. Bronchodilator response in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1986; 133: 814-19.
12. National Heart, Lung and Blood Institute. Global initiative for asthma. NHLBI/WHO April 2001, workshop report. NIH Publication no. 02-3659, Bethesda MD.
13. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 1991; 144: 1202-18.
14. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am. Rev. Respir. Dis. 1991; 143: 323-30.
15. Courbot A, Chabot F, Jankowski R et al. Sinobronchial syndrome. Rev. Mal. Respir. 2001; 18: 193-6 (in French).
16. Begin R, Masse S, Cantin A, Menard HA, Bureau MA. Airway disease in a subset of nonsmoking rheumatoid patients. Characterization of the disease and evidence for an autoimmune pathogenesis. Am. J. Med. 1982; 72: 743-50.
17. Seyama K, Nukiwa T, Souma S, Shimizu K, Kira S. Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53 [TCC] is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan. Am. J. Respir. Crit. Care Med. 1995; 152: 2119-26.
18. Yoshiyama T, Ishikawa N. Epidemiology and control activities of tuberculosis in Japan. Nippon Rinsho 2000; 58: 1167-74.
19. Eidelman DH, Ghezzo H, Kim WD, Hyatt RE, Cosio MG. Pressure-Volume curves in smokers. Comparison with alpha-1-antitrypsin deficiency. Am. Rev. Respir. Dis. 1989; 139: 1452-8.
20. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646-64.
21. Niewoehner DE, Hoidal JR. Lung fibrosis and emphysema: divergent responses to a common injury? Science 1982; 217: 359-60.
22. Hiwatari N, Shimura S, Takishima T. Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 1993; 60: 354-8.
23. Eliasson O, Degraff AC Jr. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. Am. Rev. Respir. Dis. 1985; 132: 858-64.
24. Smith AD, Cowan JO, Filsell S et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am. J. Respir. Crit. Care Med. 2004; 169: 473-8.
25. Mochizuki T, Nakajima H, Kokubu F, Kushihashi T, Adachi M. Evaluation of emphysema in patients with reversible airway obstruction using high-resolution CT. Chest 1997; 112: 1522-6.
26. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-64.